ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2021 Congress

July 17-21, 2021. Philadelphia, PA.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z
  • Abstract Number: PB0546

    Ultrasound Assessment of the Joint Status in Hemophilia Patients under Prophylaxis Using the Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) Score

    I. Ricca1, B. Pollio1, R. Albiani1, C. Martinoli2

  • Abstract Number: PO110

    Ultrasound-guided Balloon Angioplasty of Occluded Artery Accompanied by Combined Electrohydraulic Low Level Shock Wave Therapy and 125I- Mediated Gamma-intravascular Brachytherapy

    H. Mehrad1,2, H. Ahmadi Noubari3,2

  • Abstract Number: PO102

    Ultrasound-guided Catheter-based 192Ir -mediated β–brachytherapy of Neointimal Hyperplasia Accompanied by Protoporphyrin IX–loaded Microbubbles-mediated Pulsed Low Level Focused Ultrasound Sonodynamic Therapy

    H. Mehrad1,2, H. Ahmadi Noubari3,2

  • Abstract Number: PO107

    Ultrasound-guided Laser-mediated Thermal Angioplasty of Occluded Artery Accompanied by Combined 5-Aminolevulinic Acid-loaded Microbubbles-mediated Photodynamic Therapy and Catheter-based 192Ir-mediated β–brachytherapy

    H. Mehrad1,2, H. Ahmadi Noubari3,2

  • Abstract Number: PB0691

    Unclassified Bleeding Disorders and Inherited Platelet Function Disorders: Response to Desmopressin Challenge

    M. Desborough1, J. Alamelu2, S. Austin1, G. Ling1, E. Foxton3, A. McCormick3, G. Dolan1, B. Madan1

  • Abstract Number: PB0499

    Understanding the burden of Care for Haemophilia in the UK: Direct Medical Costs and Associated Predictors from the CHESS I and II Studies

    I. Woollacott1, A. Chhabra1, J. Brownrigg1, T. Burke2, A. Shaikh2, J. O'Hara2, J. Godfrey3, M. Laffan4

  • Abstract Number: OC 61.4

    Understanding the Role of Mitochondria in Platelet Function

    K.S. Prakhya1, Y. Luo2, H. Vekaria1, J. Adkins1, X. Hu2, P. Sullivan1, Q. Wang1, S. Whiteheart1

  • Abstract Number: OC 04.3

    Unraveling Mild Antithrombin Deficiency with Mass Spectrometry in a Patient Presenting with Recurrent Pregnancy Loss

    M. Kruijt1, L.M. van der Pol2, J. Eikenboom2, H.J. Verburg3, C.M. Cobbaert1, L.R. Ruhaak1

  • Abstract Number: PO168

    Unusual Laboratory Presentation of Lupus Anticoagulant: Prolonged Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) without Severe Factor Deficiency

    C. Guedes1, L. Barbosa2, D. Marques1, J. Silva1, T. Luís1, R. Salvado1, J. Tomaz1

  • Abstract Number: PB0603

    Update on Real Life Use of Emicizumsb in Pediatric Patients without Inhibitors

    S. Heine1, N. Graf1

  • Abstract Number: PB0510

    Updates on the Atlanta Protocol Cohort: Two-year Institutional Outcomes on Immune Tolerance Induction in Children with Hemophilia A and Inhibitors on Emicizumab

    G. Batsuli1, K. Zimowski1, K. Tickle2, S.L. Meeks1, R.F. Sidonio1

  • Abstract Number: PB0862

    Urgent Cardiac Surgery in a Patient with Heparin Induced Thrombocytopenia

    M. Romić1, D. Mišura1, G. Tomac2, M. Čikeš1,3, H. Gašparović1,4, A. Boban1,5

  • Abstract Number: PB0643

    Urosurgical Management in Mild Hemophilia with Inhibitor: A Case Report

    L. Phillips1, M. Movassaghi2, C.P. Carpenter2, D. Kaur1

  • Abstract Number: PB0322

    Use of Blood Products and Hemostatic Agents during Massive Transfusions: Review of our Practice

    G.S. Ene1, L. Edo Caballero2, N. Tamayo Ubeda2, A. Carpi Medina2, N. Palo Mauriz2, A. Villauvi Serra2, A. Bolivar Lopez1, P. Sanchez Coronado1, I. Sanchez Ron2, C. Raya Hinojosa2, J.C. Alvarez Garcia2

  • Abstract Number: PB0223

    Use of D-Dimer as a Predictor of Venous Thromboembolism Events (VTE) in Covid-19 Patients

    M.C. Chindamo1,2, M.B. Manhães1, L.D. Carvalho1, G.G. Sardinha1, A.M. Marques1, H.C. Goudar1, A.B. Nunes1, P.R. Carmo Jr1,2, D.R. Salgado1,2

  • Abstract Number: PB1080

    Use of Dabigatran Assessed By Thrombin Generation Assay (TGA): Paradoxical Results

    R. Duarte1, C. Ferreira2, E. Figueiredo3, G. Lopes4, L. Paes5, D. Rios6, M. Carvalho1

  • Abstract Number: PB0531

    Use of Desmopressin in the Treatment of Bleeding in Non-severe Hemophilia A

    A. Zwagemaker1, F.R. Kloosterman1, S.C. Gouw1,2, E.A.M. Beckers3, S. Boyce4, P. Collins5, J. Eikenboom6, S. Shapiro7, S. Jackson8, M.J.H.A. Kruip9, B. Laros-Van Gorkom10, L. Nieuwenhuizen11, I. Pabinger12, M. Coppens13, J.G. Van der Bom2,14, G. Castaman15, K. Fijnvandraat1,16, DYNAMO Study Group

  • Abstract Number: PB0310

    Use of MRX PT DOAC in a Routine Laboratory Setting for Detection of Interfering DOACs in Thrombophilia Investigation

    T. Lindahl1, M. Lund1, K. Arbring2, L. Onelöv3

  • Abstract Number: PB0334

    Use of Rotational Thromboelastometry (ROTEM) to Monitor Patients with Severe Haemophilia A on Emicizumab

    A. Riddell1, P. Lane1, J. Kemp1, T. Gandhi1, P. Chowdary1

  • Abstract Number: PB0783

    Use of Single Photon Emission Computed Tomography and Arthrocentesis in the Management of Hip Hemarthrosis in Hemophilia A

    J. Mooney1, P. Moorehead1, H. Martin1, A. Pickles1.

  • Abstract Number: OC 73.4

    Use of the National Early Warning Score for Predicting Deterioration of Patients with Acute Pulmonary Embolism

    R. Bavalia1, M.A.M. Stals2, FI Mulder1, IM Bistervels1,3, M Coppens1, LM Faber4, SV Hendriks2,5, HMA Hofstee6, MV Huisman2, T van der Hulle2, ATA Mairuhu5, MJHA Kruip7, S Middeldorp1,8, FA Klok2, BA Hutten9, F Holleman10

  • Abstract Number: LPB0108

    Usefulness of an Academic High-throughput Sequencing Panel to Detect Copy Number Variations in Patients with Syndromic Thrombocytopenia

    S. Santos-Mínguez1, C. Miguel-García1, V. Ramírez-Maldonado1, I. Serramito-Gómez1, A. Marín-Quilez1, J. Matías-Martín1, J.R. González-Porras1,2, H. González-García3, J. Huerta-Aragonés4, C. Blázquez-Goñi5, A. Rodríguez-Alén6, C. García-Diaz7, E. Urbaneja-Rodríguez3, A. Hortal Benito-Sendín8, N. Revilla9, V. Palma-Barqueros9, J. Rivera9, J.M. Hernández-Rivas1,2, J.M. Bastida1,2, R. Benito1

  • Abstract Number: PB0596

    Usefulness of Clot Waveform Analysis as a Perioperative Monitoring in Arthroscopic Synovectomy to a Pediatric Patient with Hemophilia A and Inhibitor Receiving Emicizumab

    K. Mizumachi1, Y. Tsumura2, Y. Nakajima1, K. Ko2, K. Nogami1

  • Abstract Number: PB0480

    Usefulness of Global Coagulation Assays to Monitor Emicizumab Therapy

    D. Bertaggia Calderara1, M.G Zermatten1, A. Aliotta1, A.P Batista Mesquita Sauvage1, L. Alberio1

  • Abstract Number: PB1248

    Usefulness of Measuring Anti–Factor Xa Activity to Guide the Treatment with Low-molecular-weight Heparins in Patients with Acute Pulmonary Embolism

    J. Bonorino1, J. Bilbao1, H. Fernandez1, N. Torres1, M. Iwanowski1, P. Alarcon1, R. Melchiori1, J. Santucci1, M.E. Aris Cancela1, P. Colimodio1, C. Rosa1, M.C. Ferrario1, P. Rubio1, S. Marquez1, G. Garcia1, M. Bivort1, A. Sanchez1, N. Perez Caceres1, S. Baratta1, A. Hita1

  • Abstract Number: PB0562

    User Evaluation of a Home-treatment Recording Smartphone App

    M. O'Donovan1,2, N. Larkin1, E. Singleton1, J. Benson1, F. McGroarty1, J. Farrelly3, C. Bergin1, R. Bird1, C. Buckley1, J.S. O'Donnell1, K. Ryan1, N.M. O'Connell1,2

  • Abstract Number: PB1251

    Using an App to Educate Patients on the Pros and Cons of Extended Anticoagulation after Venous Thromboembolism: A Randomized Controlled Trial

    M.A. de Winter1, T. Timmers2,3, M.M.C. Hovens4, A. Iglesias del Sol5, A.T.A. Mairuhu6, H.A.H. Kaasjager1, M. Nijkeuter1

  • Abstract Number: PB1226

    Using the Caprini Risk Score to Increase VTE Awareness in the Community. The Know Your Score Project

    P. Shetye1, S. Gavankar1, H. Saadaldin2,3, A. Tafur4,5, J. Caprini4,5

  • Abstract Number: PB1266

    Using the Functional Resonance Analysis Method to Explore how Elastic Compression Therapy Is Organized and Could Be Improved

    R.H. Schreurs1,2,3, M.A. Joore4, H. Ten Cate1,2,3, A.J. Ten Cate-Hoek1,2

  • Abstract Number: PB0034

    USP Potency Adjusted Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin and may be interchangeable for anticoagulation

    A. Kouta1, N. Baig1, W. Jeske1, D. Hoppensteadt1, M. Iacobelli1, O. Iqbal1, M. Bakhos1, J. Fareed1

  • Abstract Number: PB0922

    Utility of a New, Rapid Automated von Willebrand Factor (VWF) Multimer Assay for the Diagnosis of von Willebrand Disease

    J. Brodard1, R. Rubin2, D. Baumgarnter2, M. Reusser2, J.A Kremer, Hovinga2

  • Abstract Number: PB0785

    Utility of Antithrombotic Therapy in Pediatric Portal Vein Thrombosis after Endovascular Procedure

    K. Na1, R. Diaz1, J. Hernandez1, H. Justino1, C. Cohen1, S. Sartain1, Y. Lee-Kim1

  • Abstract Number: PB0411

    Utility of Lysis Time (Global Fibrinolytic Capacity) Assay for Detection of Hyperfibrinolysis in Trauma

    A. Rossetto1,2, T. Torres2, S. Platton2, P. Vulliamy1,2, R. Davenport1,2

  • Abstract Number: PB0897

    Utility of Modified Ivy’s Bleeding Time and Closure Time on Platelet Function Analyzer-200 as a Screening Tool to Identify Platelet Function Disorders

    R. Dave1, T. Geevar1, J. Mammen1, G. Chellaiya1, A. Samuel1, R. Vijayan1, S. Singh1, S. Nair1

  • Abstract Number: PB0389

    Utility of Platelet Parameters in Pediatric Outpatient Setting: Experience from a Single Institution

    R. Natesirinilkul1, S. Manowong1, P. Saihikam1

  • Abstract Number: PB1296

    Utility of Royal College of Obstetricians and Gynaecologists (RCOG) Guidelines in Preventing Pregnancy Related Venous Thrombo-embolism (PA-VTE)

    E. Jackson1, E. Treharne1, A. Alexander1, B. Myers2

  • Abstract Number: PB0355

    Utility of the STG-Bleedscreen Assay in Clinical Routine

    T. Siegemund1, A. Siegemund1, H. Bönigk1

  • Abstract Number: PB0973

    Utilizing CRISPR-CAS9 Gene Editing Technology in Human Pluripotent Stem Cells to Study Platelet Integrin αIIbβ3 Function

    K.P.Y. Fong1, C. Jobaliya2, J.A. Maguire2, M. Poncz2, D.L. French2, J.S. Bennett1

Jump to:  View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley